Samantha Kreuzberg

Treatment With Anakinra, a Recombinant IL-1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD Colitis

S. Holland, C. Zerbe, H. Malech, 2015, The American Journal of Gastroenterology.